Haemonetics (HAE) Assets Average (2010 - 2026)

Haemonetics' Assets Average history runs 17 years deep, the most recent figure standing at $2.4 billion for Q1 2026.

• On a quarterly basis, Assets Average fell 1.91% year-over-year to $2.4 billion in Q1 2026; TTM through Mar 2026 was $2.4 billion, a 1.91% decrease from a year earlier, with the FY2026 full-year figure at $2.4 billion, up 4.31% from the prior year.
• Assets Average declined to $2.4 billion in Q1 2026 per HAE's latest filing, from $2.5 billion in the prior quarter.
• Across five years, Assets Average topped out at $2.5 billion in Q3 2024 and bottomed at $1.8 billion in Q1 2022.
• The 5-year median for Assets Average is $2.2 billion (2023), against an average of $2.2 billion.
• Across the five-year window, Assets Average surged 32.77% in 2022 and fell 3.2% in 2025, its largest moves.
• Year by year, Assets Average stood at $1.9 billion in 2022, then gained by 12.52% to $2.1 billion in 2023, then increased by 20.06% to $2.5 billion in 2024, then declined by 2.44% to $2.5 billion in 2025, then decreased by 0.94% to $2.4 billion in 2026.
• Per Business Quant, the three latest HAE Assets Average figures stand at $2.4 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.5 billion (Q3 2025).